Our latest deals : Domain Therapeutics ($42M series A), Ludocare (€4.2M Seed), Spine Innovations (M&A sell-side, un-disclosed amount), Neurofenix ($7M series A), Incepto (€27M series B)
It’s launch day! 🚀 We’re proud to announce the launch of Vik Atopic Dermatitis in 3 new countries: Italy, Spain, and the United Kingdom!
Vik AD is a virtual companion for patients and loved ones who live with atopic dermatitis, a chronic inflammatory disease that substantially impacts the quality of life.
Already present in France and Germany, we’re excited to expand Vik AD around the world this year.
Developed with the support of patients, associations and physicians, Vik AD:
☝️ Provides answers to all questions 24/7
🗣 Shares tips, daily inspiration, and patient testimonials
⏰ Helps patients monitor their illness (such as symptoms, treatment, appointment reminders, etc.).
Download it here: https://lnkd.in/eHTFP72b
👏 A show of hands to all of those involved! Philippe Fernandes, PhD, Gwendolyn Jauffret, Emma Rousseau, Lucas Tidas, Tristan Voiron, Olman Hidalgo Muñoz, Belén López-Cancio, Gauthier Guicherd, Lara Bellini, PhD, Ana Marchal Quesada, Lynn Khoury, Ana Huaca Garzon RN / MPH, Axel Boulet, Monia Souidi, AADA (Asociación de Afectados por la Dermatitis Atópica)
After taking Vik Atopic Dermatitis to 9 countries and in four different languages, our main goal remains guiding patients through their search for a healthier life.
Telemedicine at the service of patients 🚀
We’re proud to announce a partnership with TeleClinic, Germany’s market leader for online consultations.
🇺🇸 After expanding to six countries this year, Vik Atopic Dermatitis completes the world tour with one more launch: the USA!
We are proud to announce the launch of Vik Colorectal in Spain! Developed with the institutional support of Pierre Fabre Group, our newest virtual companion will support patients and their loved ones living with colorectal cancer!